Q1 2026 Prepared remarks
Logotype for UTZ Brands Inc

UTZ Brands (UTZ) Q1 2026 Prepared remarks earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for UTZ Brands Inc

Q1 2026 Prepared remarks earnings summary

29 May, 2026

Executive summary

  • Net sales for Q1 2026 increased 2.6% year-over-year to $361.3 million, led by branded salty snacks organic net sales growth of 5.2% and retail sales outpacing the category at 4.6%.

  • Adjusted EBITDA rose 6.2% to $47.9 million, driven by margin expansion and productivity gains, while adjusted EPS declined 6.3% due to higher depreciation and amortization.

  • Free cash flow improved by $32.3 million year-over-year, though remained negative at -$25.9 million; net leverage ratio improved to 3.6x, the lowest Q1 ratio since going public.

  • Strategic initiatives included the closure of the Grand Rapids facility, acquisition of Insignia International's DSD assets to accelerate California expansion, and increased marketing investment by 35% year-over-year.

  • Full-year 2026 guidance was reaffirmed, with continued focus on branded portfolio, innovation, and geographic expansion.

Financial highlights

  • Q1 2026 organic net sales: $361.3 million (+2.6% YoY); branded salty snacks organic net sales up 5.2%, non-branded/non-salty snacks declined 14.3%.

  • Adjusted gross profit: $111.4 million (+10.1% YoY); adjusted gross margin: 30.8% (+210bps YoY); gross profit margin expanded to 25.4%.

  • Adjusted EBITDA: $47.9 million (+6.2% YoY); adjusted EBITDA margin: 13.3% (+50bps YoY).

  • Adjusted net income: $21.3 million (-4.5% YoY); adjusted EPS: $0.15 (-6.3% YoY); net loss attributable to controlling interest was $1.7 million.

  • Cash and equivalents: $73.7 million; total liquidity at $196.1 million; net debt: $780.3 million.

Outlook and guidance

  • Reaffirmed 2026 guidance: organic net sales growth of 2–3%, adjusted EBITDA growth of 5–8%, and adjusted EPS decline of 3–6%.

  • Adjusted free cash flow guidance maintained at $60–80 million; capital expenditures expected at $60–65 million.

  • Net leverage ratio targeted at 3.0x–3.2x by year-end.

  • 53rd week in Q4 2026 expected to benefit reported net sales by ~$20 million, adjusted EBITDA by ~$3 million, and adjusted EPS by ~2¢.

  • Category growth assumed flat for the year, with uncertainty in consumer environment and tougher comparisons in H2.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more